Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
11/2008
11/25/2008US7456154 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
11/25/2008US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule
11/25/2008CA2382588C Polymorphs of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
11/25/2008CA2348390C Compositions for the treatment and prevention of neurological and pathopsychological diseases
11/20/2008WO2008140782A2 Compounds for enzyme inhibition
11/20/2008WO2008138943A2 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
11/20/2008WO2008138115A1 Nutritional composition comprising l-carmtme fumarate, red wine extract and saw palmetto extract for maintaining skeletal muscle androgen receptivity
11/20/2008WO2008048689A3 Methods for the treatment of muscular dystrophy associated with dysferlin-deficiency
11/20/2008US20080287454 Cxcr4 antagonists
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287390 Pyrazolidinol compounds
11/20/2008US20080286329 Blood-derived plastic bone tissue articles; Young's Modulus of 0.03 GPa to 50 GPa; article; biological response modifiers hormones, growth factors, cytokines, extracellular matrix molecules; crosslinking agents iridoid derivatives, diimidates, diones; plasticizers phthalate, adipate, plant oils, glycols
11/19/2008EP1677806B1 Methods for treating acute and overuse sprain and strain using hyaluronic acid
11/19/2008EP1453539B1 Immunotherapeutic methods and systems
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/18/2008US7452529 Treatment of muscular dystrophy with cord blood cells
11/18/2008CA2440222C Triazolopyridines as anti-inflammatory agents
11/18/2008CA2381219C Monomeric protein of the tgf-beta family
11/18/2008CA2339190C Compressed compositions comprising clarified xanthan gum
11/13/2008WO2008135661A2 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
11/13/2008WO2008134844A1 Branched-chain amino acid composition for improving skeletal muscle protein metabolism
11/13/2008US20080279966 Encouraging muscle protein biosynthesis ; attenuating inflammatory signals in exercising muscles; nutritional composition; mixture of amino acid, plant extracts and gamma butyrobetaine
11/13/2008US20080279945 Water soluble gel; gene expression of nucleic acid segments encoding therapy constructs including peptides, polypeptides, ribozymes and catalytic Rna to cells or tissues of animals; cardiovascular disorders; muscular dystrophy
11/13/2008US20080279933 Flurbiprofen and muscle relaxant combinations
11/13/2008US20080279837 Composition for maintaining androgen and androgen-like uptake potential by cells
11/13/2008US20080279819 Therapeutic mixture comprising uncompetitive n-methylaspartic acid receptor antagonist, glatiramer acetate and monoclonal antibody for use in treatment of multiple sclerosis
11/13/2008CA2689608A1 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
11/13/2008CA2687107A1 Branched-chain amino acid composition for improving skeletal muscle protein metabolism
11/12/2008EP1990046A1 Condensation aerosol containing loxapine or prochlorperazine for inhalation
11/12/2008EP1988916A1 Methods and agents for reducing oxidative stress
11/12/2008EP1799709A4 Myostatin isoform
11/11/2008US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449175 Delivery of erectile dysfunction drugs through an inhalation route
11/11/2008US7449174 Delivery of analgesics through an inhalation route
11/11/2008US7449172 Delivery of antiemetics through an inhalation route
11/06/2008WO2008133132A1 Method for improvement in activities of reactive oxygen species-scavenging enzymes
11/06/2008WO2008131941A1 Treatment of movement disorders by a combined use of botulinum toxin and muscle stimulation
11/06/2008US20080275105 Thienyl-acylhydrazone derivatives; muscular disorders; antiischemic, hypotensive, and antispasmodic agents; cardiovascular and respiratory system disorders
11/06/2008US20080275013 Mixture of androgen, macrocyclic ketone enhancer and thickener; glandular disorders
11/06/2008US20080275012 Mixture of androgen, such as testosterone, macrocyclic ketone enhancer and thickener; therapy for glandular disorders
11/06/2008US20080274971 Use of ACRP30 Globular Head to Promote Increases in Muscle Mass and Muscle Differentiation
11/06/2008US20080274966 Biglycan and related therapeutics and methods of use
11/06/2008US20080274098 Method of Treating or Preventing Tissue Deterioration, Injury or Damage Due to a Neuro-, Muscular- or Neuro-Muscular-Degenerative Disease, or Restore Tissue Adversely Affected by Said Disease
11/06/2008CA2684529A1 Treatment of movement disorders by a combined use of botulinum toxin and muscle stimulation
11/05/2008EP1987823A1 Condensation aerosol containing zaleplon for inhalation
11/05/2008EP1986643A1 Treatment of duchenne muscular dystrophy
11/05/2008EP1986633A2 Treatment of duchenne muscular dystrophy
11/05/2008EP1986627A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
11/05/2008EP1385514B1 Spiroindene and spiroindane compounds
11/05/2008EP0912601B2 Suppression of immune response via inhibition of cathepsin s
11/05/2008CN101298440A Pharmaceutical salts of reboxetine
11/04/2008US7446091 Methods and preparations for curing clinically ill patients
11/04/2008US7445768 Delivery of sedative-hypnotics through an inhalation route
10/2008
10/30/2008WO2008075206A3 Cell-matrix microspheres, methods for preparation and applications
10/30/2008WO2008067480A3 Myostatin inhibition for enhancing muscle and/or improving muscle function
10/30/2008WO2008005471A3 Novel heterobicyclic compounds
10/30/2008US20080269260 Using a purine compound; antiallergens; antiinflammatory agents; cognition activators; drug abuse; schizophenia; Alzheimer's disease; Parkinson's disease
10/30/2008US20080269257 Use of Substituted 2-Pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A] Pyrimidin-4-one and 7-Pyrimidinyl-2,3-dihydroimidazo[1,2-A] Pyrimidin-5(1H)one Derivatives
10/30/2008US20080269241 Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
10/30/2008US20080269219 Oxazole compound to treat or prevent diabetic neuropathy; 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl-2-methyl-1-imidazolyl)oxazole
10/30/2008US20080269149 Adeno-associated virus (AAV); genetic engineering; parvoviruses; gene therapy; muscle delivery; glioblastoma; Parkinson's Disease
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080268489 Therapeutic polypeptide for use in treatment of heart, hypothermic and cardiovascular disorders
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267941 Nutrition Comprising Betaine Against Muscle Wasting
10/29/2008EP1986011A2 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
10/29/2008EP1985308A2 Water-soluble compositions of bioactive lipophilic compounds
10/29/2008EP1983978A2 Novel application of topical anesthetics for modulation of neurogenic tremor
10/29/2008EP1983975A2 Method of treatment for muscular dystrophy
10/29/2008EP1853280A4 Compositions and methods for treating and preventing cardiomyopathy and heart disease
10/29/2008EP1556055B1 Cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure and their use in therapy
10/29/2008EP1406650B1 Use of poly-glu, tyr for neuroprotection therapy of the cns or pns
10/29/2008CN101293043A Pharmaceutical formulation for treating muscular atrophy lateral sclerosis and preparing method
10/29/2008CN100429225C Promyostatin peptides and methods of using same
10/28/2008US7442837 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442836 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442790 Caspase inhibitors and uses thereof
10/28/2008US7442719 Methods using phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442368 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation
10/23/2008WO2008126693A1 Remedy and diagnostic for mitochondrial dysfunction brain disease
10/23/2008US20080262205 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease
10/23/2008US20080262011 N-(2-hydroxy-1-methyl-ethyl)-3-iodobenzamide; for the treatment of a muscular disorder, a gastrointestinal disorder, or for controlling spasticity or tremors; modulates cannabinoid receptors
10/23/2008US20080261976 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
10/23/2008US20080261877 Albumin Fusion Proteins
10/23/2008US20080261302 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/23/2008US20080260820 Providing effective gastrointestinal tract drug delivery; therapeutic protein having primary amino acid sequence modification
10/23/2008US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood
10/23/2008US20080260678 Molecular band-aid
10/23/2008CA2688725A1 Methods for treating spinal muscular atrophy using tetracycline compounds
10/23/2008CA2682855A1 Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases
10/22/2008EP1983055A1 Albumin fusion proteins
10/22/2008EP1981530A2 Composition containing several botulic toxins
10/22/2008EP1458394B1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3
10/22/2008CN100427093C 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor
10/21/2008US7439393 Phenethanolamine derivatives for treatment of respiratory diseases
10/21/2008US7439335 Synthetic antigen presenting matrix/biological scaffold comprising immobilized major histocompatibility complex for use in identifying modulator for treatment and prevention of autoimmune, allergy and cancer disorders
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 233